Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6132 (MIR6132) is a human gene belonging to the microRNA family of non-coding RNAs; these are short (typically 20–24 nucleotides) RNA molecules involved in the post-transcriptional regulation of gene expression by binding to target messenger RNAs (mRNAs), leading to either inhibition of translation or mRNA degradation[2][5][6]. MIR6132 is cataloged under HGNC:50272 and NCBI Gene:102466616[2]. Diseases associated with MIR6132 include Alopecia-Intellectual Disability Syndrome 1, but its specific biological role, regulated targets, or therapeutic relevance remain poorly characterized in the current literature[2]. If further specificity or functional insight emerges in curated databases or new literature, the above may be updated. At present, MIR6132 is recognized as a distinct human microRNA gene with very limited functional annotation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6132 (MIR6132).